CDChristoffel Dinant

Christoffel Dinant

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christoffel Dinant has a total of 126 co-authors. Here are the top co-authors by number of shared publications:

  • Adriaan B. Houtsmuller

    8 shared publications
  • Wim Vermeulen

    7 shared publications
  • Jiri Bartek

    Genome Integrity group, The Danish Cancer Institute, Copenhagen 2100, Denmark; Division of Genome Biology, Department of Medical Biochemistry and Biophysics, Karolinska Institute, SciLifeLab, Stockholm, Sweden

    5 shared publications
  • Jiri Bartek

    Genome Integrity Group, Danish Cancer Institute, Copenhagen, Denmark

    4 shared publications
  • Jiri Lukas

    Protein Signaling Program, Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

    4 shared publications
  • Martijn S. Luijsterburg

    Department of Cell and Molecular Biology, Karolinska Institutet, Stockholm S-17177, Sweden

    4 shared publications

Latest Publications

  • Stepwise DNA damage and repair mechanisms at replication forks in response to topoisomerase I inhibition

    by Sofie Østergård Bæk, Kristina Keuper, Giacomo Milletti, Alba Adelantado-Rubio, Michael Lisby, Jiri Bartek, Christoffel Dinant, Apolinar Maya-Mendoza


  • Open Access

    Ursolic Acid Impairs Cellular Lipid Homeostasis and Lysosomal Membrane Integrity in Breast Carcinoma Cells

    by Ditte L. Fogde, Cristina P. R. Xavier, Kristina Balnytė, Lya K. K. Holland, Kamilla Stahl-Meyer, Christoffel Dinant, Elisabeth Corcelle-Termeau, Cristina Pereira-Wilson, Kenji Maeda, Marja Jäättelä

    Cancer is one of the leading causes of death worldwide, thus the search for new cancer therapies is of utmost importance. Ursolic acid is a naturally occurring pentacyclic triterpene with a wide range of pharmacological activities including anti-inflammatory and anti-neoplastic effects. The latter has been assigned to its ability to promote apoptosis and inhibit cancer cell proliferation by poorly defined mechanisms. In this report, we identify lysosomes as the essential targets of the anti-cancer activity of ursolic acid. The treatment of MCF7 breast cancer cells with ursolic acid elevates lysosomal pH, alters the cellular lipid profile, and causes lysosomal membrane permeabilization and leakage of lysosomal enzymes into the cytosol. Lysosomal membrane permeabilization precedes the essential hallmarks of apoptosis placing it as an initial event in the cascade of effects induced by ursolic acid. The disruption of the lysosomal function impairs the autophagic pathway and likely partakes in the mechanism by which ursolic acid kills cancer cells. Furthermore, we find that combining treatment with ursolic acid and cationic amphiphilic drugs can significantly enhance the degree of lysosomal membrane permeabilization and cell death in breast cancer cells.


  • Open Access

    CtIP-dependent nascent RNA expression flanking DNA breaks guides the choice of DNA repair pathway

    by Daniel Gómez-Cabello, Giorgios Pappas, Diana Aguilar-Morante, Christoffel Dinant, Jiri Bartek

    The RNA world is changing our views about sensing and resolution of DNA damage. Here, we developed single-molecule DNA/RNA analysis approaches to visualize how nascent RNA facilitates the repair of DNA double-strand breaks (DSBs). RNA polymerase II (RNAPII) is crucial for DSB resolution in human cells. DSB-flanking, RNAPII-generated nascent RNA forms RNA:DNA hybrids, guiding the upstream DNA repair steps towards favouring the error-free Homologous Recombination (HR) pathway over Non-Homologous End Joining. Specific RNAPII inhibitor, THZ1, impairs recruitment of essential HR proteins to DSBs, implicating nascent RNA in DNA end resection, initiation and execution of HR repair. We further propose that resection factor CtIP interacts with and re-activates RNAPII when paused by the RNA:DNA hybrids, collectively promoting faithful repair of chromosome breaks to maintain genomic integrity.

  • Open Access

    A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection

    by Ana López-Saavedra, Daniel Gómez-Cabello, María Salud Domínguez-Sánchez, Fernando Mejías-Navarro, María Jesús Fernández-Ávila, Christoffel Dinant, María Isabel Martínez-Macías, Jiri Bartek, Pablo Huertas

    There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the repair of double-strand breaks by homology-independent or -dependent mechanisms is distinguished by the accumulation of green or red fluorescence, respectively. Using a genome-wide human esiRNA (endoribonuclease-prepared siRNA) library, we isolate genes that control the recombination/end-joining ratio. Here we report that two distinct sets of genes are involved in the control of the balance between NHEJ and HR: those that are required to facilitate recombination and those that favour NHEJ. This last category includes CCAR2/DBC1, which we show inhibits recombination by limiting the initiation and the extent of DNA end resection, thereby acting as an antagonist of CtIP.


  • Enhanced Chromatin Dynamics by FACT Promotes Transcriptional Restart after UV-Induced DNA Damage

    by Christoffel Dinant, Giannis Ampatziadis-Michailidis, Hannes Lans, Maria Tresini, Anna Lagarou, Malgorzata Grosbart, Arjan F. Theil, Wiggert A. van Cappellen, Hiroshi Kimura, Jiri Bartek, et al.


  • Acetylation dynamics of human nuclear proteins during the ionizing radiation-induced DNA damage response

    by Martin Bennetzen, Dorthe Larsen, Christoffel Dinant, Sugiko Watanabe, Jiri Bartek, Jiri Lukas, Jens S. Andersen

    Genotoxic insults, such as ionizing radiation (IR), cause DNA damage that evokes a multifaceted cellular DNA damage response (DDR). DNA damage signaling events that control protein activity, subcel...


  • Open Access

    Histone Displacement during Nucleotide Excision Repair

    by Christoffel Dinant, Jiri Bartek, Simon Bekker-Jensen

    Nucleotide excision repair (NER) is an important DNA repair mechanism required for cellular resistance against UV light and toxic chemicals such as those found in tobacco smoke. In living cells, NER efficiently detects and removes DNA lesions within the large nuclear macromolecular complex called chromatin. The condensed nature of chromatin inhibits many DNA metabolizing activities, including NER. In order to promote efficient repair, detection of a lesion not only has to activate the NER pathway but also chromatin remodeling. In general, such remodeling is thought on the one hand to precede NER, thus allowing repair proteins to efficiently access DNA. On the other hand, after completion of the repair, the chromatin must be returned to its previous undamaged state. Chromatin remodeling can refer to three separate but interconnected processes, histone post-translational modifications, insertion of histone variants and histone displacement (including nucleosome sliding). Here we review current knowledge, and speculate about current unknowns, regarding those chromatin remodeling activities that physically displace histones before, during and after NER.


  • TRIP12 and UBR5 Suppress Spreading of Chromatin Ubiquitylation at Damaged Chromosomes

    by Thorkell Gudjonsson, Matthias Altmeyer, Velibor Savic, Luis Toledo, Christoffel Dinant, Merete Grøfte, Jirina Bartkova, Maria Poulsen, Yasuyoshi Oka, Simon Bekker-Jensen, et al.


  • Open Access

    Recognition of DNA damage by XPC coincides with disruption of the XPC–RAD23 complex

    by Steven Bergink, Wendy Toussaint, Martijn S. Luijsterburg, Christoffel Dinant, Sergey Alekseev, Jan H.J. Hoeijmakers, Nico P. Dantuma, Adriaan B. Houtsmuller, Wim Vermeulen

    The recognition of helix-distorting deoxyribonucleic acid (DNA) lesions by the global genome nucleotide excision repair subpathway is performed by the XPC–RAD23–CEN2 complex. Although it has been established that Rad23 homologs are essential to protect XPC from proteasomal degradation, it is unclear whether RAD23 proteins have a direct role in the recognition of DNA damage. In this paper, we show that the association of XPC with ultraviolet-induced lesions was impaired in the absence of RAD23 proteins. Furthermore, we show that RAD23 proteins rapidly dissociated from XPC upon binding to damaged DNA. Our data suggest that RAD23 proteins facilitate lesion recognition by XPC but do not participate in the downstream DNA repair process.


  • Open Access

    The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage

    by Dorthe Helena Larsen, Catherine Poinsignon, Thorkell Gudjonsson, Christoffel Dinant, Mark R. Payne, Flurina J. Hari, Jannie M. Rendtlew Danielsen, Patrice Menard, Jette Christensen Sand, Manuel Stucki, et al.

    In response to ionizing radiation (IR), cells delay cell cycle progression and activate DNA repair. Both processes are vital for genome integrity, but the mechanisms involved in their coordination are not fully understood. In a mass spectrometry screen, we identified the adenosine triphosphate–dependent chromatin-remodeling protein CHD4 (chromodomain helicase DNA-binding protein 4) as a factor that becomes transiently immobilized on chromatin after IR. Knockdown of CHD4 triggers enhanced Cdc25A degradation and p21Cip1 accumulation, which lead to more pronounced cyclin-dependent kinase inhibition and extended cell cycle delay. At DNA double-strand breaks, depletion of CHD4 disrupts the chromatin response at the level of the RNF168 ubiquitin ligase, which in turn impairs local ubiquitylation and BRCA1 assembly. These cell cycle and chromatin defects are accompanied by elevated spontaneous and IR-induced DNA breakage, reduced efficiency of DNA repair, and decreased clonogenic survival. Thus, CHD4 emerges as a novel genome caretaker and a factor that facilitates both checkpoint signaling and repair events after DNA damage.